Dyadic International Inc. (DYAI)
NASDAQ: DYAI
· Real-Time Price · USD
1.10
-0.07 (-5.98%)
At close: Sep 26, 2025, 3:59 PM
1.11
0.91%
After-hours: Sep 26, 2025, 07:05 PM EDT
Dyadic International Revenue Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Grant Revenue | 503.18K | 210.47K | 465.17K | 1.43M | n/a | n/a | 220.59K | 44.12K | 44.12K | 44.12K | n/a | 835.48K | 614.43K | 114.71M |
| Grant Revenue Growth | +139.07% | -54.75% | -67.36% | n/a | n/a | -100.00% | +400.00% | 0.00% | 0.00% | n/a | -100.00% | +35.98% | -99.46% | n/a |
| License Revenue | 250K | 183.1K | 352.21K | 532.5K | 385.9K | 334.62K | 465.95K | 352.94K | 793.04K | 933.93K | n/a | 44.12K | 44.12K | 533.72M |
| License Revenue Growth | +36.54% | -48.01% | -33.86% | +37.99% | +15.32% | -28.19% | +32.02% | -55.50% | -15.09% | n/a | -100.00% | 0.00% | -99.99% | n/a |
| Research and Development Revenue | 213.45K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Research and Development Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 1.44M | 1.6M | 1.44M | 1.3M | 1.61M | 1.79M | 1.65M | 1.28M | 1.4M | 1.48M | 1.67M | 1.38M | 1.71M | 1.66M | 1.7M | 1.69M | 1.75M | 1.55M | 1.31M | 1.64M | 1.48M | 1.65M | 1.16M | 1.06M | 1.87M | 1.43M | 1.28M | 1.02M | 921.54K | 1.29M | 1.9M | 868.69K | 1.23M | 1.25M | 1.64M | 939.2K | 1.09M | 891.98K | 620.12K | 1M | 1.35M | 829.15K |
| Selling, General, and Administrative Revenue Growth | -10.00% | +10.82% | +10.98% | -19.27% | -10.11% | +8.27% | +28.83% | -8.57% | -5.23% | -11.29% | +20.59% | -19.29% | +3.52% | -2.79% | +0.61% | -3.13% | +12.46% | +18.38% | -20.13% | +11.41% | -10.78% | +41.92% | +10.30% | -43.54% | +30.99% | +11.17% | +25.49% | +11.08% | -28.73% | -31.94% | +118.70% | -29.59% | -1.24% | -23.78% | +74.51% | -13.99% | +22.42% | +43.84% | -38.03% | -26.09% | +63.28% | n/a |
| Research and Development Revenue | 213.45K | 183.1K | 545.66K | 460.24K | 515.63K | 522.72K | 852.8K | 716.35K | 917.55K | 810.57K | 584.12K | 743.59K | 1.83M | 1.34M | 2.47M | 1.9M | 2.21M | 1.81M | 1.01M | 986.05K | 1.12M | 755.45K | 776.73K | 943.19K | 1.15M | 1.08M | 640.88K | 764.81K | 942.05K | 969.43K | 671.77K | 792.05K | 419.75K | 319.52K | -78.07K | 369.36K | 349.38K | 244.93K | 124.01K | n/a | n/a | n/a |
| Research and Development Revenue Growth | +16.58% | -66.44% | +18.56% | -10.74% | -1.36% | -38.70% | +19.05% | -21.93% | +13.20% | +38.77% | -21.45% | -59.38% | +36.34% | -45.71% | +30.08% | -13.93% | +22.19% | +78.94% | +2.47% | -11.66% | +47.75% | -2.74% | -17.65% | -18.31% | +6.72% | +68.81% | -16.20% | -18.81% | -2.82% | +44.31% | -15.19% | +88.70% | +31.37% | -509.27% | -121.14% | +5.72% | +42.64% | +97.51% | n/a | n/a | n/a | n/a |